Lv1
70 积分 2020-05-23 加入
SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7
2天前
已完结
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
2天前
已完结
Process optimization to remove immunoglobulin A, immunoglobulin M and prekallikrein activator for intravenous immunoglobulin G production
3天前
已完结
Efficient Synthesis of Crisaborole from m-Cresol: A Practical and Scalable Process
4天前
已完结
Anticancer Properties of Halogenated Pyrrolo[3,2‐d]pyrimidines with Decreased Toxicity via N5 Substitution
4天前
已完结
Crystal forms of SK-3530
4天前
已完结
Metabolism and excretion of 5‐ethyl‐2‐{5‐[4‐(2‐hydroxyethyl)piperazine‐1‐sulfonyl]‐2‐propoxyphenyl}‐7‐propyl‐3,5‐dihydropyrrolo[3,2‐ d ]‐pyrimidin‐4‐one (SK3530) in rats
4天前
已完结
Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives
4天前
已完结
Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats
4天前
已完结
Pharmacokinetics of mirodenafil and Its two metabolites, SK3541 and SK3544, in spontaneously or DOCA–salt‐induced hypertensive rats
4天前
已完结
皖公网安备34019202002308
